Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Lam CSP, Ramasundarahettige C, Branch KRH et al (2022) Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial
Quick guide: Who may be eligible for GLP-1
10.1038/nature14344 29 JinM
Research reports present research findings and objective analysis that address the challenges facing the public and private sectors
According to the CVS Health 2025 Rx Report, nearly half of consumers prioritize personalized care at the pharmacy, and many prefer in-person pharmacy support over digital-only options - highlighting the ongoing importance of face-to-face interactions with pharmacists
L-
US$ 27.94
US$ 26.32
US$ 26.04
